In partnership with
Enrollment’s wrapped for the late-stage breast cancer study, and the chart’s doing victory laps. Cool your jets as the next real catalyst is data, which means volatility, fundraises, and mood swings can sneak in. Let’s look at what to do if you’re in the name.
Wyoming is on the Verge of Becoming A Lithium Powerhouse
America needs 5X more lithium by 2035, but no new mines have opened since 1967. Meanwhile, current extraction methods are slow, waste insane amounts of water, and emit loads of carbon.
So Vero3 devised a way to cleanly produce lithium, generate clean water and permanently store carbon in the process – all from the same 14,000-acre Wyoming site.
This first-of-its-kind project is already validated by $25M in historical funding and projects $183M in annual profit.
This unique project offers exposure to three different markets, each covering a critical need for America. And shares are now open to the public ahead of commercial trials and a targeted 2028 Nasdaq IPO.
This is a paid advertisement for Vero3 Limited’s Regulation CF offering. Please read the offering circular at https://invest.vero3.com/. Timelines are subject to change. Listing on the NASDAQ is contingent upon necessary approvals, and reserving a ticker symbol does not guarantee a company’s public listing.
Futures at a Glance📈
Wall Street’s lacing up for a heavyweight earnings week and a splash of inflation drama. Hopes are rising that tariff talk cools off as D.C. hints at more carve-outs, and traders are rotating back into risk after last week’s whiplash.
The shutdown is still the unwanted roommate, data is patchy, and CPI drops later this week like a pop quiz. Big names line up on deck, think streamers, sodas, chips, and EVs, so consider today the warm-up lap before the main event.
Want to make sure you never miss a pre-market alert?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.
Email’s great. Texts are faster.
You’ll be first in line when the market starts moving.
What to Watch
Premarket Earnings:
Summit Therapeutics [SMMT]
Cleveland-Cliffs [CLF]
Aftermarket Earnings:
W. R. Berkley [WRB]
Steel Dynamics [STLD]
Crown Holdings [CCK]
AGNC Investment [AGNC]
Wintrust Financial [WTFC]
Zions Bancorporation [ZION]
BOK Financial [BOKF]
Economic Reports:
Leading Economic Indicators [Sept.]: 10:00 am
Biotech
Exelixis Cancer Combo Shows Real Survival Lift
Exelixis (NASDAQ: EXEL) rolled out detailed trial results showing its new combo helped people with tough-to-treat colon cancer live longer than today’s go-to option.
That’s real progress, and the company says it’s moving toward a U.S. filing. The stock still wobbled because Wall Street’s favorite game after big medical conferences is “nice news, what’s next?”
This is great data as a step one. Now comes the grind with regulators, the label, doctor adoption, insurance coverage, and a launch that doesn’t blow the budget. Post-event sell the news is common, so swings are part of the ride.
My Take For You: If you’re up, trim a slice into strength and trail a stop, you can always add back after the first pullback holds. If you’re eyeing an entry, let the dust settle and look for a calm base rather than chasing green.
Track the filing timeline, feedback from cancer specialists, and any early pricing or coverage signals. A steady cadence of updates matters more than one standing ovation.
My Verdict: Solid, de-risking step for a real medicine. Watchlist or small position is fair; add on weakness, not adrenaline.
Crypto
Ice-Bath Mining Finds a Warm Bid at BitMine
BitMine Immersion Technologies (NYSEAMERICAN: BMNR) is back in the spotlight as analysts slapped on fresh “buy” tags and targets that make hodlers grin. The business model is simple to love in this tape: keep the machines cool, stack blocks, and sell a growth story while crypto wakes up.
A fresh wave of institutional interest, plus a strong coin tape this morning, turned the volume knob past eleven.
Reality check is the guidance still points to losses for now, and high-beta miners can trade like a roller coaster in a thunderstorm. Rates, power costs, and coin swings all tug on margins, and this chart has already visited the stratosphere and the basement this year.
My Take For You: Trade it, don’t tattoo it. Starter size only on green days, and add on orderly dips or a tight consolidation. If you’re up big, peel some and let a runner ride with a stop just below breakout.
Keep an eye on any new capacity adds, power contracts, and whether management funds growth without turning the share count into confetti.
My Verdict: Momentum rental with coin-wind at its back. Great when the music’s playing; keep your shoes by the door.
Banks Enter Crypto (Sponsored)
In July, crypto history was made.
Congress passed the first federal framework for digital assets—and almost overnight, the market surged past $4 trillion.
Here’s why:
✓ Banks now have the green light to offer crypto services.
✓ Wall Street institutions can finally scale in.
✓ The uncertainty holding crypto back is gone.
This is the moment early movers have been waiting for.
Our Crypto Revolution report shows you exactly how to prepare—and it’s 100% free.
You’ll also get $788 in bonus resources when you claim your copy.
The floodgates are open.
Don’t wait until the crowd catches on.
[Claim Your Free Copy Today]
© 2025 Boardwalk Flock LLC. All Rights Reserved. 2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States
*The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.
Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.
Biotech
Patients In, Hopes Up at Celcuity
Celcuity (NASDAQ: CELC) just filled the last seat in its big breast-cancer study targeting a common mutation, and traders rang the bell like the market opened early. Full enrollment means the stopwatch finally starts: fewer ifs, more whens, and a shorter road to real results.
Add some encouraging early signals and you’ve got a mid-cap rocket that suddenly thinks it’s a large cap.
This finishing recruitment is a milestone, not a finish line. You still need clean data, clean safety, and a review that doesn’t sprout surprise questions. Small biotechs also love to raise cash after giant green days, because science isn’t cheap and trials burn money like a candle at both ends.
My Take For You: If you caught the pop, feed the ducks and trail a stop under the prior day’s low. If you’re flat, hunt a red-to-green flip or pullback toward rising support rather than paying peak excitement.
Watch for the next timetable update, any hints on additional studies, and financing moves that change share count. Early chatter is great; results are rent due.
My Verdict: Speculative buy on controlled dips only. Celebrate the milestone, but let the data do the heavy lifting before sizing up.
Poll: You inherit $250K tomorrow. What do you do first?
Movers and Shakers
Sable Offshore [SOC]: Premarket Move: +16%
An insider just wrote a fat check, but the chart’s still nursing bruises from that pipeline court smackdown. The bull pitch is Plan B, as tankers keep barrels moving while the legal saga grinds on, while the bear pitch is one-project risk with regulators sitting in the front row.
Cute pop, heavy baggage.
My Take: Treat this like surfing after a storm. Ride the clean sets, bail on the chop. If you play it, keep size small, use a tight stop under yesterday’s lows, and don’t hang around if headlines turn.
Critical Metals [CRML]: Premarket Move: +9%
Fresh $50M in the war chest to push Tanbreez in Greenland, and rare earths are still wearing the geopolitical cape. Funding helps the from rock to revenue story, but dilution is real, and timelines move slower than your broker on hold.
My Take: Rent the rerate, don’t buy the mine. Trim into strength, look to add only on orderly pullbacks toward rising support, and demand actual build milestones before upgrading from trade to hold.
Grail [GRAL]: Premarket Move: +8%
A $325M private raise, plus that Samsung tie-up, has the balance sheet doing yoga. More runway is great for go-to-market on early cancer detection, but new shares mean slice-sharing for everyone. Execution now shifts from lab coats to reimbursement and distribution.
My Take: Momentum-friendly stock while the funding glow lasts, but respect the dilution. Starter size on green, add on red days near the 20/50-day, and reassess after the next commercial update or payer win.
Early Entry Advantage (Sponsored)
The market rewards those who act early.
That’s why our team has just released an all-new report—5 Stocks Set to Double.
These picks were chosen because they stand out with:
Rock-solid fundamentals for confidence
Technical strength pointing to breakout potential
In the past, this exact type of report has uncovered stocks that posted triple digit runs of +175%, +498%, even +673%.
The new report is free—but only until midnight tonight.
Download your free copy here before time runs out
Don’t just settle for growth. Aim for massive.
Everything Else
Big-box is leaning into nostalgia as Target and Walmart load up on trading cards for the holidays, because nothing says festive like ripping packs.
A threatened movie tariff could smack Britain especially hard, which is awkward when your cinematic special effects and actors commute across the Atlantic.
Mixed signals from China growth as retail and factories did their chores, property’s still grounded, and markets are trying to decide if this is a soft landing.
An overnight cloud outage at AWS reminded everyone that the internet runs on someone else’s computer, as a bunch of sites took an unscheduled coffee break.
Engine headaches are so bad that Airbus jets barely out of the box are getting parted out, which is like buying a new car just to sell the tires.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
